My ePortfolio Register   

Lifetime achievement award and future work

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.11.11
Views: 4581

Prof Christopher Marshall - The Institute of Cancer Research, London, UK

Prof Christopher Marshall speaks with Prof Gordon McVie at the National Cancer research Institute cancer conference in Liverpool on his lifetime achievement award; work with RAS and current research on RHO.

Prof Marshall earned his award for elucidating how RAS proteins function, which led to numerous targeted drugs currently used in the clinic, many of which came from research outside his work on RAS. In his current research, Prof Marshall is researching RHO, a family of proteins similar to RAS that allow tumour cells to invade and metastasise. While RAS proteins are important in invasion and metastasis, RHO affects a different process of the cell and gives them the ability to change shape and move.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence